Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma

Leuk Lymphoma. 2015 Jan;56(1):270-3. doi: 10.3109/10428194.2014.914196. Epub 2014 Jun 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma / pathology*
  • Lymphoma / therapy*
  • Recurrence
  • Siblings*
  • Transplantation, Homologous
  • Treatment Outcome